Status:
NO_LONGER_AVAILABLE
Long-Term Compassionate Use Study for Continued Administration of SCB01A-01
Lead Sponsor:
SynCore Biotechnology Co., Ltd.
Conditions:
Malignant Solid Tumour
Eligibility:
All Genders
18+ years
Brief Summary
The primary objective is to characterize the safety profile of long-term exposure to SCB01A when administered to cancer subjects with advanced solid tumors. Furthermore, the efficacy profile will also...
Detailed Description
This is a companion study to the protocol SCB01A-01 intended to provide long-term continued administration to subjects that completed Protocol SCB01A-01 on a compassionate basis. It is an open-label, ...
Eligibility Criteria
Inclusion
- Subjects who completed protocol SCB01A-01 and exhibited a favorable response or had no clinical evidence of disease progression (i.e. stable disease, partial response or complete response).
Exclusion
- Study participants meeting any of the following criteria will be excluded from enrollment:
- Unwilling or unable to provide informed consent.
- Unwilling or unable to comply with the requirements of the protocol.
- Has unresolved toxicities from previous SCB01A-01 protocol.
Key Trial Info
Start Date :
Trial Type :
EXPANDED_ACCESS
End Date :
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT01151930
Last Update
November 17 2020
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.